DaVita
DVA
#1723
Rank
โ‚น1.142 T
Marketcap
โ‚น17,803
Share price
-3.01%
Change (1 day)
68.76%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): โ‚น1,150

According to DaVita's latest financial reports the company's current EPS (TTM) is โ‚น1,185. In 2025 the company made an earnings per share (EPS) of โ‚น960.89 a decrease over its 2024 EPS that were of โ‚น1,047.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,15019.72%
2025โ‚น960.89-8.25%
2024โ‚น1,04744.94%
2023โ‚น722.5727.26%
2022โ‚น567.80-35.56%
2021โ‚น881.1444.1%
2020โ‚น611.4819.7%
2019โ‚น510.83540.48%
2018โ‚น79.76-76.07%
2017โ‚น333.27-19.31%
2016โ‚น413.03242.52%
2015โ‚น120.59-62.87%
2014โ‚น324.7313.43%
2013โ‚น286.278.45%
2012โ‚น263.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
โ‚น2,358 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,156-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
โ‚น2,480 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
โ‚น200.94-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA